Patient Guide: Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer’s disease: results of a multicenter, double-blind, randomized, placebo-controlled, clinical trial in three parallel groups

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 6 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06292351
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: Alzheimer’s disease, mild to moderate dementia
Phase: PHASE2

Find a Study Location Near You

This study is available at 6 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Saint Petersburg,
  • Yaroslavl,
  • Moscow,
  • • And 3 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily